Survival after non-traumatic spinal cord injury: evidence from a population-based rehabilitation cohort in Switzerland.


Journal

Spinal cord
ISSN: 1476-5624
Titre abrégé: Spinal Cord
Pays: England
ID NLM: 9609749

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 22 08 2018
accepted: 10 10 2018
revised: 05 10 2018
pubmed: 11 11 2018
medline: 8 6 2019
entrez: 11 11 2018
Statut: ppublish

Résumé

Observational cohort study. To investigate survival and life expectancy after NTSCI in Switzerland according to etiology. Specialized rehabilitation centers in Switzerland. Longitudinal data from the Swiss Spinal Cord Injury (SwiSCI) medical records study were used. Adjusted hazard ratios (HRs) and life expectancies were estimated using flexible parametric survival modeling. One thousand four hundred and fifty individuals were admitted to first rehabilitation for NTSCI between 1990 and 2011, contributing 6137 cumulative person-years at risk and 528 deaths. With reference to persons with a degenerative disc disorder, the HR for mortality in individuals with NTSCIs from infections was 1.42 (95% CI 0.99-2.04), while risk in those with NTSCIs from vascular disorders was 1.28 (95% CI 0.97-1.68). Mortality risk was most pronounced in individuals with NTSCIs from malignant neoplasms (HR 6.32, 95% CI 4.79-8.34). Exemplified for males with an attained age of 60 years, a malignant etiology was associated with 1.7 life years remaining (LYR), as compared to 10.1 LYR for non-malignant etiologies. Males with an attained age of 60 years and a degenerative disc etiology were estimated to have 12.9 LYR. This study contributes an evidence base for risk factors of mortality after NTSCI, reducing a considerable knowledge gap in survival after NTSCI. Survival and life expectancy estimates were highly differential between etiological groups, indicating a need for a heterogeneous clinical approach and dynamic health-care provisions for this growing population.

Identifiants

pubmed: 30413804
doi: 10.1038/s41393-018-0212-x
pii: 10.1038/s41393-018-0212-x
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-275

Références

Spinal Cord. 2014 Feb;52(2):97-109
pubmed: 23318556
Spine (Phila Pa 1976). 2010 Apr 1;35(7):796-802
pubmed: 20228702
Spinal Cord. 2018 Oct;56(10):920-930
pubmed: 29895883
BMC Med Res Methodol. 2013 Dec 07;13:152
pubmed: 24314264
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):824-31
pubmed: 20630663
J Rehabil Med. 2016 Feb;48(2):120-30
pubmed: 26926916
J Spinal Cord Med. 2015 Nov;38(6):754-64
pubmed: 25615237
Aust Health Rev. 2006 Aug;30(3):353-61
pubmed: 16879094
Top Spinal Cord Inj Rehabil. 2017 Fall;23(4):313-323
pubmed: 29339907
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Spinal Cord. 2017 Jun;55(6):540-544
pubmed: 28169294
Spinal Cord. 2014 Feb;52(2):123-32
pubmed: 23295473
Neuroepidemiology. 2015;44(3):182-98
pubmed: 25997873
J Spinal Cord Med. 2012 Mar;35(2):89-95
pubmed: 22333497
J Spinal Cord Med. 2015 Nov;38(6):765-76
pubmed: 26111282
Top Spinal Cord Inj Rehabil. 2017 Fall;23(4):353-367
pubmed: 29339911
Am J Epidemiol. 2018 Mar 1;187(3):623-632
pubmed: 29020256
Swiss Med Wkly. 2017 May 10;147:w14430
pubmed: 28488262
Am J Phys Med Rehabil. 2011 Nov;90(11 Suppl 2):S5-16
pubmed: 21975676
Arch Phys Med Rehabil. 2004 Sep;85(9):1499-502
pubmed: 15375824
Spinal Cord. 2008 Jun;46(6):406-11
pubmed: 18071356
Spinal Cord. 2011 May;49(5):596-9
pubmed: 21135863
Am J Epidemiol. 2010 Aug 15;172(4):478-87
pubmed: 20616200
Spinal Cord. 2017 Aug;55(8):759-764
pubmed: 28555665

Auteurs

A Buzzell (A)

Swiss Paraplegic Research, Nottwil, Switzerland.
Department of Health Sciences and Health Policy, University of Lucerne, Lucerne, Switzerland.

J D Chamberlain (JD)

Swiss Paraplegic Research, Nottwil, Switzerland.
Department of Health Sciences and Health Policy, University of Lucerne, Lucerne, Switzerland.
Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.

H P Gmünder (HP)

Swiss Paraplegic Center, Nottwil, Switzerland.

K Hug (K)

REHAB Basel, Basel, Switzerland.

X Jordan (X)

Clinique Romand de Réadaption, Sion, Switzerland.

M Schubert (M)

Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland.

M W G Brinkhof (MWG)

Swiss Paraplegic Research, Nottwil, Switzerland. martin.brinkhof@paraplegie.ch.
Department of Health Sciences and Health Policy, University of Lucerne, Lucerne, Switzerland. martin.brinkhof@paraplegie.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH